Filing Details
- Accession Number:
- 0001645627-18-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-31 12:44:14
- Reporting Period:
- 2018-12-21
- Accepted Time:
- 2018-12-31 12:44:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | No | No |
Transaction Summary
| Purchased: | 138,000 shares | Avg. Price: $0.02 | Total Value: $2,542.70 |
| Number of Shares After Transactions: | 26,505,898 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-21 | 2,000 | $0.02 | 26,369,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,372,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,375,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 10,000 | $0.02 | 26,385,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 10,000 | $0.02 | 26,395,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 10,000 | $0.02 | 26,405,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,410,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,415,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,416,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,417,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,422,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,423,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 10,000 | $0.02 | 26,433,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,434,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,439,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,440,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 2,000 | $0.02 | 26,442,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,443,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,444,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,449,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 20,000 | $0.02 | 26,469,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,470,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 2,000 | $0.02 | 26,472,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 3,000 | $0.02 | 26,475,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 2,000 | $0.02 | 26,477,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 10,000 | $0.02 | 26,487,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 5,000 | $0.02 | 26,492,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 2,000 | $0.02 | 26,494,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 10,000 | $0.02 | 26,504,898 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-21 | 1,000 | $0.02 | 26,505,898 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
